Immunosuppression is associated with an increased risk of distant metastases in high-risk cutaneous squamous cell carcinoma: A retrospective cohort study

JAAD Int. 2023 Dec 15:15:74-77. doi: 10.1016/j.jdin.2023.11.006. eCollection 2024 Jun.

Cristian Cardona-Machado¹, Javier Martín-Vallejo², Sara Becerril-Andrés³, David Revilla-Nebreda³, Laura Moralejo¹, Jesús Pérez-Losada^{1

4}, Javier Cañueto^{1

3

4

5}

¹ Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Laboratory 20, Universidad de Salamanca/CSIC, Campus Miguel de Unamuno s/n, Salamanca, Spain.
² Department of Statistics, Faculty of Medicine, University of Salamanca, Salamanca, Spain.
³ Department of Dermatology, University Hospital of Salamanca, Salamanca, Spain.
⁴ Department of Medicine, Faculty of Medicine, University of Salamanca, Salamanca, Spain.
⁵ Instituto de Investigación Biomédica de Salamanca (IBSAL), Hospital Universitario de Salamanca, Salamanca, Spain.

No abstract available

Keywords: cutaneous squamous cell carcinoma; immunosuppression; outcome measures; staging systems.